Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02665065
Title Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML (SIERRA)
Acronym SIERRA
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Actinium Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.